In the BioHarmony Drug Report Database

"Preview" Icon

Serdexmethylphenidate

Azstarys (serdexmethylphenidate) is a small molecule pharmaceutical. Serdexmethylphenidate was first approved as Azstarys on 2021-05-07. It is used to treat attention deficit disorder with hyperactivity in the USA. Azstarys’s patents are valid until 2037-12-09 (FDA).

 

Trade Name

 

Azstarys
 

Common Name

 

serdexmethylphenidate
 

ChEMBL ID

 

CHEMBL4301162
 

Indication

 

attention deficit disorder with hyperactivity
 

Drug Class

 

Image (chem structure or protein)

Serdexmethylphenidate structure rendering